{"doc_desc":{"title":"PrimInject : \u00e9tude transversale sur les modes et les pratiques de consommation de drogues en France","idno":"FRESH-PEF73177-fr","producers":[{"name":"Romain GUIGNARD","affiliation":"SANTE PUBLIQUE FRANCE"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73177-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"73177"},{"agency":"FReSH","code":"FRESH-PEF73177"}]},"title":"PrimInject : \u00e9tude transversale sur les modes et les pratiques de consommation de drogues en France","alternate_title":""},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"type":"investigator","name":"Pierre;ARWIDSON","PILabo":"Sant\u00e9 publique France","affiliationName":"SANTE PUBLIQUE FRANCE","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"057593922","role":"pi id"},{"title":"SIREN","uri":"130022338","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"pierre.arwidson@santepubliquefrance.fr","isContact":"Oui"},{"type":"investigator","name":"Romain;GUIGNARD","PILabo":"Sant\u00e9 publique France","affiliationName":"SANTE PUBLIQUE FRANCE","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"181046172","role":"pi id"},{"title":"SIREN","uri":"130022338","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"romain.guignard@santepubliquefrance.fr","isContact":"Oui"},{"type":"investigator","name":"Anne;GUICHARD","PILabo":"Universit\u00e9 Laval, Qu\u00e9bec","affiliationName":"UNIVERSITE LAVAL","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"28185629X","role":"pi id"},{"title":"SIREN","uri":"831483318","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"anne.guichard@fsi.ulaval.ca","isContact":"Oui"}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"SANTE PUBLIQUE FRANCE","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/00dfw9p58","role":"sponsor id"},{"title":"SIREN","uri":"130022338","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":"SANTE PUBLIQUE FRANCE","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/00dfw9p58"},{"title":"SIREN","uri":"130022338"}]}]},"distribution_statement":{"contact":[{"name":"Pierre;ARWIDSON","email":"pierre.arwidson@santepubliquefrance.fr","type":"contact","affiliationName":"SANTE PUBLIQUE FRANCE","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/00dfw9p58","role":"organisation id","title":"ROR"},{"uri":"130022338","role":"organisation id","title":"SIREN"}]},{"name":"Romain;GUIGNARD","email":"romain.guignard@santepubliquefrance.fr","type":"contact","affiliationName":"SANTE PUBLIQUE FRANCE","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/00dfw9p58","role":"organisation id","title":"ROR"},{"uri":"130022338","role":"organisation id","title":"SIREN"}]},{"name":"Anne;GUICHARD","email":"anne.guichard@fsi.ulaval.ca","type":"contact","affiliationName":"UNIVERSITE LAVAL","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/04sjchr03","role":"organisation id","title":"ROR"},{"uri":"831483318","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[],"topics":[{"topic":"Infectiologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/fa2ceeab-3b2f-45e9-9243-e5a8005b98de"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D055552"}]},{"topic":"D\u00e9terminants comportementaux : Addictions","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux","vocab":"health determinant"}],"purpose":"L\u2019injection par voie intraveineuse est le mode de transmission majeur du VHC chez les usagers de drogues, non seulement par le partage de la seringue, mais aussi par celui du mat\u00e9riel de pr\u00e9paration (r\u00e9cipient, filtre, tampon, eau), possiblement souill\u00e9 par le sang d\u2019une personne contamin\u00e9e. Selon diff\u00e9rentes sources, on assiste depuis quelques ann\u00e9es \u00e0 des changements significatifs dans les modes et les pratiques de consommation de drogues en France, sous l\u2019effet conjoint de la diffusion massive des traitements de substitution aux opiac\u00e9s (bupr\u00e9norphine haut dosage ou BHD) \u00e0 partir de 1995 et de l\u2019arriv\u00e9e sur le march\u00e9 d\u2019une grande vari\u00e9t\u00e9 de stimulants, incluant la coca\u00efne et les drogues de synth\u00e8se. Souvent non planifi\u00e9es et pratiqu\u00e9es par un tiers \u00ab initiateur \u00bb, les premi\u00e8res injections sont \u00e0 haut risque de contamination pour le jeune initi\u00e9, souvent peu au fait des techniques d\u2019injection et des risques infectieux encourus et pas en contact avec les structures de premi\u00e8re ligne. Dans ce contexte, une enqu\u00eate a \u00e9t\u00e9 mise en place pour identifier les circonstances et les pratiques de(s) la premi\u00e8re(s) injection(s) parmi les jeunes usagers de drogues en France. Une m\u00e9thodologie utilisant internet a \u00e9t\u00e9 d\u00e9velopp\u00e9e pour permettre d\u2019acc\u00e9der et ainsi de d\u00e9couvrir des profils d\u2019usagers \u00e9chappant aux dispositifs d\u2019observation plus \u00ab classiques \u00bb, en particulier ceux qui se trouvent socialement int\u00e9gr\u00e9s ou qui ne sont pas en contact avec les structures.","abstract":"","coll_dates":[{"start":"2010-01-01","end":"2011-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Masculin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adolescence (13 \u00e0 18 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000293\"\n            }\n        },\n        {\n            \"value\": \"Adulte (19 \u00e0 24 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adulte (25 \u00e0 44 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Adulte (45 \u00e0 64 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Population g\u00e9n\u00e9rale\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Etre \u00e2g\u00e9 de plus de 15 ans. Les individus ne s'\u00e9tant jamais inject\u00e9 de drogues \u00e9taient redirig\u00e9s vers une version courte du questionnnaire.\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es rapport\u00e9es par le participant de l'\u00e9tude']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":"['Pr\u00e9-test des outils et du questionnaire aupr\u00e8s d\\'usagers de drogues par voie intraveineuse. V\u00e9rification et nettoyage de la base de donn\u00e9es sous Stata.']"}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Ev\u00e9nements de sant\u00e9\/morbidit\u00e9\r\nAutres"}]},"method":{"data_collection":{"time_method":"Etude transversale non r\u00e9p\u00e9t\u00e9e","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":""}},"coll_mode":["{\"concept\":{\"vocabURI\":\"MeasurementsAndTests.Physical\",\"vocab\":\"CESSDA\"},\"value\":\"Mesures physiques\/biologiques (tension art\u00e9rielle, poids, biochimie, imagerie...)\"}","{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Transcription et saisie d\u2019informations dans un enregistrement structur\u00e9\"}"],"research_instrument":"Acc\u00e8s restreint sur projet sp\u00e9cifique","sources":[],"target_sample_size":"[500-1000[ individus","response_rate":"449 injecteurs et 455 non-injecteurs"},"method_notes":"Etude observationnelle","study_class":"\u00c9tude compl\u00e9t\u00e9e","notes":[{"subject":"research type","values":["Etude observationnelle"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Acc\u00e8s r\u00e9serv\u00e9\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"}]}"},"dataset_use":{"restrictions":"","conditions":"Sur demande aupr\u00e8s de Pierre Arwidson, Directeur des affaires scientifiques de l'Inpes.","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"23-07-2015","lastUpdatedAuto":null,"lastUpdatedManual":"19-09-2017","isContributorPI":"Non","contributorName":"Romain GUIGNARD","contributorAffiliation":"SANTE PUBLIQUE FRANCE","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[{"type":"","title":"Practices related to the first injection according to the key periods of the risk reduction policy in France. Article published in Drug and Alcohol Dependence.","link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23726980"}],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Public (France)"],"otherFundingAgentType":[""]},"sponsor":{"sponsorType":["Public (France)"],"otherSponsorType":[""]},"governance":{"committee":"Oui"},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"Non","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"Internet. Promotion de l'enqu\u00eate via une campagne de banni\u00e8res Web, affiches d\u00e9clin\u00e9es en format cart-com, articles et communiqu\u00e9s de presse.","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"Non"},"geographicalCoverage":{"geoDetail":"France"},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","isDataInBiobank":"Non","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Oui","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}